The fifth annual "Accelerating Research & Treatments for Castleman disease" working dinner meeting will be held December 3, 2016 at 7:30-9:30pm at the American Society of Hematology Annual Meeting in San Diego, CA.
Meeting location: Manchester Grand Hyatt San Diego
Registration: Click here to sign up!
Goals: We plan to have an even larger audience this year and discuss key CDCN priorities including a global patient registry, diagnostic criteria discussion, patient care, and international research agenda.
Sponsorship: Janssen Pharmaceuticals has generously sponsored this meeting for the fourth year in a row! We want to express our gratitude to Janssen Pharmaceuticals for their continued support of the Castleman disease community!
History: The CDCN held its first "Accelerating research & treatment for Castleman disease" meeting at the American Society of Hematology (ASH) 2012 meeting in Atlanta, GA. Thirty physicians, physician-scientists, and pharmaceutical partners from around the world joined us to share the latest discoveries around Castleman disease, which demonstrated clinician interest, determined initial priorities, and built tremendous momentum for the CDCN.
The CDCN held a second "Accelerating research & treatment for Castleman disease" meeting at ASH 2013 meeting in New Orleans, LA. A diverse group of over 50 hematologists, pathologists, physician-scientists, translational researchers, and pharmaceutical partners joined us for the meeting, which focused on the gaps that exist in the current state of knowledge and means for filling those gaps.
Over 50 physicians and researchers attended the CDCN's third annual "Accelerating research and treatment for Castleman disease" meeting during ASH 2014 meeting in San Francisco, CA.
The fourth annual meeting during ASH 2015 in Orlando, FL was a huge success with over 50 physicians and researchers attending and key priorities coming from the meeting.